Heron Therapeutics Stock Analysis, Valuation (NASDAQ:HRTX)

Add to My Stocks
$33.8 $0.85 (2.45%) HRTX stock closing price Sep 17, 2018 (Closing)

Take a look at Amigobulls Heron Therapeutics stock analysis video. Our HRTX analysis video highlights revenue and profit trends along with other important metrics such as valuation to find what makes the stock attractive.

Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.

Heron Therapeutics Inc Stock Rating 1.6/5

Amigobulls HRTX stock analysis uses latest quarter 2018 Q2 financial data like Heron Therapeutics revenue growth, profit margins and cash flows. We also use relative valuation metrics like PE ratio and price to sales ratio for Heron Therapeutics valuation analysis. Based on a company's historical fundamentals we arrive at Heron Therapeutics stock rating which is indicative of the company's financial performance.

Should you buy HRTX stock?

  • Heron Therapeutics's revenue growth came in at 103.1% in 2018-06.

Should you sell HRTX stock?

  • Over the last twelve months, Heron Therapeutics posted an average operating loss margin of -408.78.
  • Heron Therapeutics registered an average TTM Net loss of -411.4%.
  • The lack of profits renders the PE ratio useless for HRTX stock.
  • The company is trading at a price to sales multiple of 59, which is overvalued in comparison to the Medical sector average multiple of 6.5.
  • Heron Therapeutics has a negative return on equity of -235. This indicates that the firm is inefficient at generating profits.

Comments on this video and Heron Therapeutics stock

Amigobulls Heron Therapeutics stock analysis helps in evaluating the financial statements of a company to arrive at a conclusion about the fair value of HRTX stock. Company's fundamentals remain one of the key driver of HRTX stock and helps investors in making good buy and sell decision.

While doing a study of the company financials, Heron Therapeutics revenue growth and profit or net income are two main metrics which help in identifying whether HRTX stock is overvalued or undervalued. One can also combine technical analysis and fundamental analysis to get a holistic picture about HRTX stock.